Combination Chemotherapy in Treating Young Patients With Nonmetastatic Rhabdomyosarcoma

NCT00379457 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

600

Enrollment

OTHER

Sponsor class

Conditions

Sarcoma

Interventions

BIOLOGICAL: dactinomycin
DRUG: carboplatin
DRUG: cyclophosphamide
DRUG: doxorubicin hydrochloride
DRUG: etoposide
DRUG: ifosfamide
DRUG: topotecan hydrochloride
DRUG: vincristine sulfate
DRUG: vinorelbine tartrate
PROCEDURE: conventional surgery
RADIATION: radiation therapy

Sponsor

European Paediatric Soft Tissue Sarcoma Study Group

Collaborators

[object Object]
[object Object]
[object Object]